Last updated: November 19, 2025
Medically reviewed by: NKF Education Team
People living with chronic kidney disease (CKD) continue to face higher risks from COVID-19, including infection, hospitalization, long COVID, and death. Even with overall improvements in outcomes, mortality after COVID-19 remains more than twice as high in people with CKD compared with those without it. Risk rises as CKD progresses and is highest in patients on dialysis and kidney transplant recipients.
This infographic offers a quick, practical overview of how to reduce COVID-19 risk and manage infection in patients with CKD. It highlights available treatment options specifically tailored for patients with CKD, including key dosing considerations, patient education pearls, side effect management, and guidance for navigating key drug interactions. Use this resource to support quick, evidence-based decisions in your everyday practice.
Connect with Us
For Kidney Health Professionals Who Want to Stay Informed
Opt in to receive education opportunities for professionals, resources for your patients, or updates from NKF.
Information contained in this NKF educational resource is based on data available at the time of publication. It is intended to help clinicians stay informed about new scientific findings and developments. This resource is not intended to establish a preferred standard of care and should not be interpreted as prescribing an exclusive course of management.
© 2025 National Kidney Foundation, Inc.